StockUS listing USFSNUYPINKHealthcareValue Trap

Fresenius SE & Co KGaA ADR(FSNUY) Stock Analysis | Healthcare

USD --+0.00%
Reward41Moderate
Risk46Moderate
75%Data
6.5% dividend yield
USD —+0.00 (+0.00%) Previous close · PINK
Market cap 33.79Bn
Reward Ratingⓘ41 Moderate reward assessment · 75% data coverage
Bottom 10% of stocksView factors
Risk Ratingⓘ46 Moderate risk assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on FSNUY to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Fresenius SE & Co KGaA ADR?

KGaA, a health care company, provides products and services for chronically ill patients.

AI Brief Pro

The brief on Fresenius SE & Co KGaA ADR

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is Fresenius SE & Co KGaA ADR?

KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Kabi and Fresenius Helios segment. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 33.79B, and a P/E ratio of 25.0x.

Financial Highlights

Investment Breakdown

Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
Profitability
Thin or inconsistent margins weigh on earnings quality.
Risk
Risk profile appears balanced versus broad market conditions.
Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (41)

Similar stocks to compare

A short list of Medical Care Facilities names that are close enough in size to make side-by-side comparison useful.

Company Information
SectorHealthcare
IndustryMedical Care Facilities
Beta0.904
Insider Activity
12M windowNo data
No insider activity data available for this ticker.